AI assistant
AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2015
Apr 27, 2015
31580_dirs_2015-04-27_dfee4f4b-cb61-4895-a5e8-17eb5d9614cc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2015-04-23
Reporting Person: Cantley Lewis Clayton Jr. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-04-23 | Common stock | S | 2426 | $103.82 | Disposed | 174540 | Direct |
| 2015-04-23 | Common stock | S | 2426 | $103.83 | Disposed | 174540 | Indirect |
| 2015-04-24 | Common stock | S | 2426 | $106.45 | Disposed | 172114 | Direct |
| 2015-04-24 | Common stock | S | 2426 | $106.49 | Disposed | 172114 | Indirect |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $102.81 to $104.79. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F3: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $102.81 to $104.70. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F4: Shares held by Vicki Lee Sato, who is the reporting person's spouse.
F5: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $104.16 to $107.23. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
F6: The price reported is the weighted average of the shares sold. The shares were sold at varying prices in the range of $104.16 to $107.20. The reporting person undertakes, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.